NaProTechnology bases on the study of the normal and abnormal conditions of both the menstrual and fertility cycles in women. The first women’s health science to network reproductive health with family planning, the science uses a fertility care model rather than a fertility control approach. The patient and her doctor use the biomarkers from NaProTechnology and the tenets of the Creighton Model FertilityCare (CrMS) System to recognize, monitor, and assess the hormonal events occurring through the menstrual cycle. Information gathered in this way is then available for interpretation by the patient and her doctor for use in reproductive and overall health decisions.
The evaluations used in NaProTechnology give a detailed picture of the patient’s fertility cycle. For a couple trying to conceive, this often leads to revelations regarding the actual timing of ovulation, versus the couple’s perception of it. It’s a natural alternative to medical interventions, such as in vitro fertilization, intrauterine insemination, or drug-based fertility methods. Should infertility not be due to poor timing, NaProTechnology then considers treatments to restore a naturally functioning reproductive cycle.
NaProTechnology works together with CrMS and its charting. The patient learns to understand and identify fertility signs. Doctors fluent in CrMS, like Dr. Lugo-Eschenwald, analyze the patient’s chart for abnormal patterns, as well as using the chart for timing things such as hormone tests and ultrasounds. Timing is important when evaluating infertility, since hormone levels swing dramatically, day-by-day. Where conventional infertility testing looks at hormones twice a month, NaProTechnology uses about 10 tests in the same period for a much more detailed look at fertility cycles. Certain abnormal patterns of ovulation are also missed using conventional approaches. NaProTechnology examines the egg release process in greater detail to determine infertility.
Feel free to email us regarding any scheduling or general questions!